AMRN FY 2016 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$130M+59.1% YoY

Gross Profit

$96M73.6% margin

Operating Income

-$66M-50.4% margin

Net Income

-$86M-66.4% margin

EPS (Diluted)

$-8.20

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$72M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$167M

Total Liabilities

$176M

Stockholders' Equity

-$9M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$130M	$82M	+59.1%
Gross Profit	$96M	$54M	+77.7%
Operating Income	-$66M	-$98M	+33.2%
Net Income	-$86M	-$115M	+25.0%